Raymond James Financial Inc Xeris Biopharma Holdings, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 13,150 shares of XERS stock, worth $48,655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,150Holding current value
$48,655% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XERS
# of Institutions
144Shares Held
60.2MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$38.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$28.7 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$18.9 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$12.9 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$12.3 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $503M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...